{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:21:14Z","timestamp":1792689674070,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.berh.2024.102020","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T21:53:45Z","timestamp":1730584425000},"page":"102020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2024.102020_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3899\/jrheum.200367","article-title":"The prevalence of rheumatoid arthritis: a systematic review of population-based studies","volume":"48","author":"Almutairi","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib2","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mpmed.2021.12.002","article-title":"Clinical features of rheumatoid arthritis","volume":"50","author":"Colquhoun","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.berh.2024.102020_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.102020_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.rdc.2022.07.004","article-title":"Atherosclerotic cardiovascular risk stratification in the rheumatic diseases:: an integrative, multiparametric approach","volume":"49","author":"Misra","year":"2023","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2024.102020_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001084","article-title":"Management of fatigue in rheumatoid arthritis","volume":"6","author":"Pope","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102020_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/ar3813","article-title":"Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA)","volume":"14","author":"Too","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.102020_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102020_bib9","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/rheumatology\/keaa623","article-title":"Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study","volume":"60","author":"Paalanen","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102020_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40064-015-0835-8","article-title":"Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome","volume":"4","author":"Draibe","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.berh.2024.102020_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","article-title":"Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-na\u00efve patients classified according to the 2010 ACR\/EULAR criteria","volume":"76","author":"Nordberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102020_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000752","article-title":"Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR\/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial","volume":"4","author":"Nordberg","year":"2018","journal-title":"RMD Open"},{"issue":"Suppl 7A","key":"10.1016\/j.berh.2024.102020_bib13","article-title":"Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2024.102020_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00296-006-0133-4","article-title":"Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian patients","volume":"26","author":"Agrawal","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.102020_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0049-0172(90)90001-V","article-title":"The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis","volume":"19","author":"Baer","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib16","article-title":"Methotrexate induced pancytopenia","volume":"2014","author":"Gonzalez-Ibarra","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib17","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1345\/aph.1E012","article-title":"Leflunomide-associated pancytopenia with or without methotrexate","volume":"38","author":"Chan","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.berh.2024.102020_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12288-014-0349-5","article-title":"Acquired pure red cell aplasia in a patient of rheumatoid arthritis","volume":"30","author":"Parida","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.berh.2024.102020_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000000011","article-title":"Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases","volume":"93","author":"Mekinian","year":"2014","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2024.102020_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1874312901408010129","article-title":"Felty's syndrome, insights and updates","volume":"8","author":"Owlia","year":"2014","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.berh.2024.102020_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","article-title":"Felty's syndrome","volume":"18","author":"Balint","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3899\/jrheum.080429","article-title":"Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs","volume":"36","author":"Kauppi","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0034-1376371","article-title":"A review of the diagnosis and treatment of atlantoaxial dislocations","volume":"4","author":"Yang","year":"2014","journal-title":"Global Spine J"},{"key":"10.1016\/j.berh.2024.102020_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.rdc.2017.06.005","article-title":"Neurologic manifestations of rheumatoid arthritis","volume":"43","author":"DeQuattro","year":"2017","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2024.102020_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/1529-0131(199807)41:7<1196::AID-ART8>3.0.CO;2-R","article-title":"Subclinical peripheral nerve involvement in patients with rheumatoid arthritis","volume":"41","author":"Lanzillo","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib26","article-title":"Rheumatoid neuropathy: a brief overview","volume":"15","author":"Rajeshwari","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.berh.2024.102020_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/BOR.0000000000000126","article-title":"Rheumatoid vasculitis: an update","volume":"27","author":"Makol","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-017-0667-3","article-title":"Rheumatoid vasculitis: a diminishing yet devastating menace","volume":"19","author":"Kishore","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2024.102020_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/20009666.2017.1340731","article-title":"Large endocardial rheumatoid nodules: a case report and review of the literature","volume":"7","author":"Vantrease","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.berh.2024.102020_bib30","first-page":"84","article-title":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis","volume":"33","author":"Chauhan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/acr.22455","article-title":"Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation","volume":"67","author":"Lazzerini","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102020_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1513\/AnnalsATS.202107-876CME","article-title":"Airway disease in rheumatoid arthritis","volume":"19","author":"Matson","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.berh.2024.102020_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0044-1782218","article-title":"Overview of rheumatoid arthritis-associated interstitial lung disease and its treatment","volume":"45","author":"Pugashetti","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.berh.2024.102020_bib34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2024.102020_bib35","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.102020_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14171890","article-title":"A systematic review of the key predictors of progression and mortality of rheumatoid arthritis-associated interstitial lung disease","volume":"14","author":"Groseanu","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.berh.2024.102020_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152187","article-title":"Survival of adults with rheumatoid arthritis associated interstitial lung disease - a systematic review and meta-analysis","volume":"60","author":"Farquhar","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152561","article-title":"Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"69","author":"Zhang","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib39","first-page":"1237","article-title":"Incidence and classification of cutaneous manifestations in rheumatoid arthritis","volume":"14","author":"Ziemer","year":"2016","journal-title":"JDDG J German Soc Dermatol"},{"key":"10.1016\/j.berh.2024.102020_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/rheumatology\/35.8.752","article-title":"Raynaud's phenomenon in rheumatoid arthritis","volume":"35","author":"Saraux","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.det.2015.03.004","article-title":"Rheumatoid nodules","volume":"33","author":"Tilstra","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.berh.2024.102020_bib42","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s10067-020-05004-8","article-title":"Prevalence of Sj\u00f6gren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry","volume":"39","author":"Harrold","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10102118","article-title":"Rheumatoid arthritis associated episcleritis and scleritis: an update on treatment perspectives","volume":"10","author":"Promelle","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.berh.2024.102020_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001472","article-title":"Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis","volume":"7","author":"Bonnet","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102020_bib45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/ar3256","article-title":"Renal co-morbidity in patients with rheumatic diseases","volume":"13","author":"Anders","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.102020_bib46","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s10067-017-3804-5","article-title":"Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals","volume":"36","author":"Mori","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib47","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00296-020-04694-2","article-title":"Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates","volume":"40","author":"Misra","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.102020_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jsps.2014.03.002","article-title":"Practical issues with high dose methotrexate therapy","volume":"22","author":"Al-Quteimat","year":"2014","journal-title":"Saudi Pharmaceut J"},{"key":"10.1016\/j.berh.2024.102020_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s41100-018-0180-9","article-title":"Methotrexate-induced acute kidney injury in patients with hematological malignancies: three case reports with literature review","volume":"4","author":"Kitamura","year":"2018","journal-title":"Renal Replacement Therapy"},{"key":"10.1016\/j.berh.2024.102020_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1116489","article-title":"Rheumatoid arthritis and the risk of end-stage renal disease: a nationwide, population-based study","volume":"10","author":"Suh","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.berh.2024.102020_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/s101650200025","article-title":"Renal involvement in rheumatoid arthritis: analysis of renal biopsy specimens from 100 patients","volume":"12","author":"Makino","year":"2002","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.1780380213","article-title":"Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis","volume":"38","author":"Helin","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib53","first-page":"28","article-title":"Rheumatoid vasculitis presenting with incidental renal infarcts: case report and literature review","volume":"13","author":"Halilu","year":"2023","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"5","key":"10.1016\/j.berh.2024.102020_bib101","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5114\/reum.2014.46669","article-title":"Renal involvement in rheumatoid arthritis","volume":"52","author":"Raczkiewicz","year":"2014","journal-title":"Reumatologia"},{"key":"10.1016\/j.berh.2024.102020_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/PL00011217","article-title":"Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis","volume":"21","author":"Kuroda","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib55","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","author":"Quarta","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2024.102020_bib56","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1053\/j.ajkd.2006.03.036","article-title":"Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy","volume":"47","author":"Sucker","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.berh.2024.102020_bib57","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S2665-9913(24)00090-0","article-title":"Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries","volume":"6","author":"Bolla","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2024.102020_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101831","article-title":"Cardiovascular risk in vasculitis","volume":"37","author":"Misra","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rdc.2022.08.001","article-title":"Venous thromboembolism in the inflammatory rheumatic diseases","volume":"49","author":"Misra","year":"2023","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2024.102020_bib61","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3899\/jrheum.161154","article-title":"Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA?","volume":"44","author":"Myasoedova","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib62","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/annrheumdis-2016-211066","article-title":"Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks","volume":"76","author":"Holmqvist","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102020_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102815","article-title":"Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis","volume":"129","author":"Karpouzas","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.berh.2024.102020_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ehjcvp\/pvab052","article-title":"An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries","volume":"8","author":"Rollefstad","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.berh.2024.102020_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001724","article-title":"Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit","volume":"7","author":"Semb","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102020_bib66","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1007\/s10067-022-06349-y","article-title":"The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study","volume":"41","author":"Muhammed","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib67","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kex038","article-title":"Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries","volume":"56","author":"Crowson","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102020_bib68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.102020_bib69","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10067-022-06415-5","article-title":"Cardiovascular risks associated with Janus kinase inhibitors: peering outside the black box","volume":"42","author":"Misra","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrrheum.2014.31","article-title":"Rheumatoid arthritis: rheumatoid vasculitis - down but not out","volume":"10","author":"Watts","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00393-015-1632-z","article-title":"Toxic epidermal necrolysis due to therapy with cyclophosphamide and mesna. A case report of a patient with seronegative rheumatoid arthritis and rheumatoid vasculitis","volume":"75","author":"Chowdhury","year":"2016","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2169\/internalmedicine.3866-19","article-title":"Severe mononeuritis multiplex due to rheumatoid vasculitis in rheumatoid arthritis in sustained clinical remission for decades","volume":"59","author":"Tanemoto","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.berh.2024.102020_bib73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2024.102020_bib74","doi-asserted-by":"crossref","first-page":"S725","DOI":"10.1097\/RHU.0000000000001541","article-title":"Bywaters lesions","volume":"27","author":"Dourado","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib75","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/omcr\/omw071","article-title":"Refractory rheumatoid vasculitis","volume":"2016","author":"Kumar","year":"2016","journal-title":"Oxf Med Case Rep"},{"key":"10.1016\/j.berh.2024.102020_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill Consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/ket326","article-title":"Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102020_bib78","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/rheumatology\/ket475","article-title":"Vasculitis associated with rheumatoid arthritis: a case-control study","volume":"53","author":"Makol","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102020_bib79","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s10067-020-05459-9","article-title":"Biological therapy in rheumatoid vasculitis: a systematic review","volume":"40","author":"de Cerqueira","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib80","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3899\/jrheum.181397","article-title":"Rituximab therapy for systemic rheumatoid vasculitis: indications, outcomes, and adverse events","volume":"47","author":"Coffey","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib81","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/s10165-011-0559-8","article-title":"The rapid efficacy of abatacept in a patient with rheumatoid vasculitis","volume":"22","author":"Fujii","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib82","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/RHU.0000000000001337","article-title":"Marked effectiveness of intravenous immunoglobulin therapy against intractable lower Leg ulcers in two patients with rheumatoid vasculitis","volume":"27","author":"Nogi","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20016-x","article-title":"The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis","volume":"12","author":"Moshayedi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2024.102020_bib84","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","article-title":"Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"29","author":"Jin","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2024.102020_bib85","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-020-05360-w","article-title":"Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2024.102020_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bone.2018.06.008","article-title":"The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized, controlled trials","volume":"114","author":"Blavnsfeldt","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.berh.2024.102020_bib87","doi-asserted-by":"crossref","first-page":"244","DOI":"10.12688\/wellcomeopenres.17208.1","article-title":"Frailty in people with rheumatoid arthritis: a systematic review of observational studies","volume":"6","author":"Hanlon","year":"2021","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.berh.2024.102020_bib88","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semarthrit.2020.10.002","article-title":"The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: a systematic review and meta-regression analysis","volume":"51","author":"Li","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib89","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10067-022-06454-y","article-title":"Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis","volume":"42","author":"Ben Tekaya","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib90","doi-asserted-by":"crossref","first-page":"835","DOI":"10.11124\/JBIES-22-00048","article-title":"Incidence of severe infection in patients with rheumatoid arthritis taking biologic agents: a systematic review","volume":"21","author":"Makimoto","year":"2023","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.berh.2024.102020_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152562","article-title":"Efficacy and safety of abatacept in preclinical rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"69","author":"Asif","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102020_bib92","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2021-222006","article-title":"EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update","volume":"81","author":"Landew\u00e9","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102020_bib93","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.102020_bib94","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.berh.2019.03.011","article-title":"Malignancy and rheumatoid arthritis: epidemiology, risk factors and management","volume":"32","author":"DeCock","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102020_bib95","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41598-020-60621-2","article-title":"Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population \u2013 the Nord-Tr\u00f8ndelag Health Study","volume":"10","author":"Houge","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2024.102020_bib96","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/annrheumdis-2015-209058","article-title":"Improved survival in rheumatoid arthritis: a general population-based cohort study","volume":"76","author":"Zhang","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102020_bib97","doi-asserted-by":"crossref","first-page":"232","DOI":"10.12968\/bjcn.2022.27.5.232","article-title":"The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis","volume":"27","author":"Hill","year":"2022","journal-title":"Br J Community Nurs"},{"key":"10.1016\/j.berh.2024.102020_bib98","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/rheumatology\/key075.533","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102020_bib99","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00296-018-4102-5","article-title":"Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study","volume":"38","author":"Walter","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.102020_bib100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/acr.24805","article-title":"Inflammatory arthritis and the effect of physical activity on quality of life and self-reported function: a systematic review and meta-analysis","volume":"74","author":"Bj\u00f6rk","year":"2022","journal-title":"Arthritis Care Res"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:17:39Z","timestamp":1741897059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521694224000913"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.102020","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.102020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102020"}}